Conclusion: This study reveals that FOXM1-ZIC2-UBE2C-mTOR signaling axis promotes the progression of ccRCC, which can be used as a prognostic indicator and potential therapeutic target. This evidence concerns the gene ZIC2 and nonpapillary renal cell carcinoma.